Sonendo (SONX) Stock Price, News & Analysis

Company Overview

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

Key Stats

• Today's Range: $1.10 to $1.10
• 50-Day Range: $1.03 to $1.69
• 52-Week Range: $1.00 to $19.94
• Volume: 470 shs
• Average Volume: 1,062 shs
• Market Capitalization: $471,900.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Sonendo Stock Analysis - MarketRank™

Sonendo scored higher than 14% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Sonendo.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Sonendo is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sonendo is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Sonendo has a P/B Ratio of 0.01. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.49% of the outstanding shares of Sonendo have been sold short.

Short Interest Ratio / Days to Cover

Sonendo has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

Short interest in Sonendo has recently decreased by 8.70%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Sonendo does not currently pay a dividend.

Dividend Growth

Sonendo does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.49% of the outstanding shares of Sonendo have been sold short.

Short Interest Ratio / Days to Cover

Sonendo has a short interest ratio ("days to cover") of 4.2.

Change versus previous month

Short interest in Sonendo has recently decreased by 8.70%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.50

News Sentiment

Sonendo has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.64 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Sonendo this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sonendo insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 7.90% of the stock of Sonendo is held by insiders.

Percentage Held by Institutions

Only 28.68% of the stock of Sonendo is held by institutions.

SONX Stock Analysis - Frequently Asked Questions

How have SONX shares performed this year?

Sonendo's stock was trading at $1.81 at the beginning of 2025. Since then, SONX shares have decreased by 39.2% and is now trading at $1.10.
View the best growth stocks for 2025 here.

How were Sonendo's earnings last quarter?

Sonendo, Inc. (NYSE:SONX) released its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.04. The company earned $8.31 million during the quarter, compared to the consensus estimate of $7.60 million. Sonendo had a negative trailing twelve-month return on equity of 184.01% and a negative net margin of 92.74%.

When did Sonendo IPO?

Sonendo (SONX) raised $125 million in an IPO on Friday, October 29th 2021. The company issued 7,800,000 shares at a price of $15.00-$17.00 per share.

How do I buy shares of Sonendo?

Shares of SONX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Sonendo own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sonendo investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Taiwan Semiconductor Manufacturing (TSM), XPeng (XPEV), nCino (NCNO), PayPal (PYPL) and Construction Partners (ROAD).

Company Calendar

• Last Earnings: 8/07/2024
• Today: 6/04/2025
• Next Earnings (Estimated): 6/10/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Dental equipment & supplies
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:SONX
• CIK: 1407973
• Web: www.sonendo.com
• Phone: 949-766-3636
• Fax: N/A
• Employees: 250
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($59.12)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$60.92 million
• Net Margins: -92.74%
• Pretax Margin: -105.16%
• Return on Equity: -184.01%
• Return on Assets: -68.60%

Debt

• Debt-to-Equity Ratio: 0.55
• Current Ratio: 1.82
• Quick Ratio: 1.22

Sales & Book Value

• Annual Sales: $44.40 million
• Price / Sales: 0.01
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $89.42 per share
• Price / Book: 0.01

Miscellaneous

• Outstanding Shares: 429,000
• Free Float: 393,000
• Market Cap: $471,900.00
• Optionable: Not Optionable
• Beta: 1.39